Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials

By sjmartinez • April 27, 2023

Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Tchouakam Kouekam H, Johnsson E, Esser MT, Hoover K, Neytman G, Newell M, Daar ES, Fischer W, Fletcher CV, Li JZ, Greninger AL, Coombs RW, Hughes MD, Smith D, Wohl DA; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team. Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials. JAMA Netw Open. 2023 Apr 3;6(4):e2310039. doi: 10.1001/jamanetworkopen.2023.10039. PMID: 37099295.

Tags: Infectious Diseases, Publications

Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes

Sundar KG, Yang LZ, Cambou MC, Varella IRS, Melo MG, Segura ER, Ziegler ÂP, Santos BR, Nielsen-Saines K. Prompt Initiation of Maternal Antiretroviral Therapy After[...]

Factors Associated With PrEP Utilization and Access in the United States

David HM, Martin T, Wells A, Little SJ, Mehta S. Factors Associated With PrEP Utilization and Access in the United States. AIDS Educ Prev. 2024[...]

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.